86 related articles for article (PubMed ID: 7693121)
1. Purification of a 15-ketoprostaglandin delta 13-reductase from rat liver and its ability to reduce the double bond of xenobiotics.
Kitamura S; Katsura H; Tatsumi K
Biochem Mol Biol Int; 1993 Aug; 30(5):839-47. PubMed ID: 7693121
[TBL] [Abstract][Full Text] [Related]
2. Multiplicity of rat liver 15-ketoprostaglandin delta 13-reductases.
Kitamura S; Katsura H; Tatsumi K
Prostaglandins; 1996 Jul; 52(1):35-49. PubMed ID: 8875636
[TBL] [Abstract][Full Text] [Related]
3. 15-Ketoprostaglandin delta 13-reductase activity in bovine ocular tissues.
Nikaido H; Moriishi M; Mishima HK; Kitamura S; Tatsumi K
Curr Eye Res; 1993 Jan; 12(1):17-22. PubMed ID: 8382144
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of salicylhydroxamic acid reductase from rat liver.
Katsura H; Kitamura S; Tatsumi K
Arch Biochem Biophys; 1993 May; 302(2):356-61. PubMed ID: 8489240
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of NAD-dependent morphine 6-dehydrogenase from hamster liver cytosol, a new member of the aldo-keto reductase superfamily.
Todaka T; Yamano S; Toki S
Arch Biochem Biophys; 2000 Feb; 374(2):189-97. PubMed ID: 10666297
[TBL] [Abstract][Full Text] [Related]
6. Purification and some properties of two enzymes from rat liver cytosol that catalyze carbonyl reduction of 6-tert-butyl-2, 3-epoxy-5-cyclohexene-1,4-dione, a metabolite of 3-tert-butyl-4-hydroxyanisole.
Tajima K; Hashizaki M; Yamamoto K; Narimatsu S; Mizutani T
Arch Biochem Biophys; 1999 Jan; 361(2):207-14. PubMed ID: 9882448
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene B4 12-hydroxydehydrogenase/15-ketoprostaglandin Delta 13-reductase (LTB4 12-HD/PGR) responsible for the reduction of a double-bond of the alpha,beta-unsaturated ketone of an aryl propionic acid non-steroidal anti-inflammatory agent CS-670.
Itoh K; Yamamoto K; Adachi M; Kosaka T; Tanaka Y
Xenobiotica; 2008 Mar; 38(3):249-63. PubMed ID: 18274955
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of alpha,beta-ketoalkene double bond reductases from bovine eyes.
Takeda Y; Mishima HK; Kitamura S; Tatsumi K
Curr Eye Res; 1997 Apr; 16(4):327-32. PubMed ID: 9134321
[TBL] [Abstract][Full Text] [Related]
9. Purification and partial characterization of a methylglyoxal reductase from goat liver.
Ray M; Ray S
Biochim Biophys Acta; 1984 Nov; 802(1):119-27. PubMed ID: 6386056
[TBL] [Abstract][Full Text] [Related]
10. Effect of NADH-X on cytosolic glycerol-3-phosphate dehydrogenase.
Prabhakar P; Laboy JI; Wang J; Budker T; Din ZZ; Chobanian M; Fahien LA
Arch Biochem Biophys; 1998 Dec; 360(2):195-205. PubMed ID: 9851831
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of rat liver naloxone reductase that is identical to 3alpha-hydroxysteroid dehydrogenase.
Yamano S; Nakamoto N; Toki S
Xenobiotica; 1999 Sep; 29(9):917-30. PubMed ID: 10548452
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a 15-ketoprostaglandin delta 13-reductase from bovine lung.
Hansen HS
Biochim Biophys Acta; 1979 Jul; 574(1):136-45. PubMed ID: 224937
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of human biliverdin reductase.
Maines MD; Trakshel GM
Arch Biochem Biophys; 1993 Jan; 300(1):320-6. PubMed ID: 8424666
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of a doxorubicin-inhibited NADH-quinone (NADH-ferricyanide) reductase from rat liver plasma membranes.
Kim C; Crane FL; Faulk WP; Morré DJ
J Biol Chem; 2002 May; 277(19):16441-7. PubMed ID: 11875069
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics.
Martin HJ; Breyer-Pfaff U; Wsol V; Venz S; Block S; Maser E
Drug Metab Dispos; 2006 Mar; 34(3):464-70. PubMed ID: 16381663
[TBL] [Abstract][Full Text] [Related]
16. Purification of NADPH-linked alpha,beta-ketoalkene double bond reductase from rat liver.
Kitamura S; Tatsumi K
Arch Biochem Biophys; 1990 Oct; 282(1):183-7. PubMed ID: 2171428
[TBL] [Abstract][Full Text] [Related]
17. Preliminary profiles of 13,14-dihydroprostaglandin F2 alpha synthetase catalyzing conversion of 13,14-dihydro-15-ketoprostaglandin F2 alpha to 13,14-dihydroprostaglandin F2 alpha in rat ovary.
Inazu N; Harasawa Y; Satoh T
Arch Int Pharmacodyn Ther; 1988; 291():272-9. PubMed ID: 3365066
[TBL] [Abstract][Full Text] [Related]
18. Ubiquinone redox cycle as a cellular antioxidant defense system.
Kishi T; Takahashi T; Usui A; Okamoto T
Biofactors; 1999; 10(2-3):131-8. PubMed ID: 10609874
[TBL] [Abstract][Full Text] [Related]
19. Purification and properties of 3 alpha-hydroxysteroid dehydrogenase as a 3-keto bile acid reductase from human liver cytosol.
Kudo K; Amuro Y; Hada T; Higashino K
Biochim Biophys Acta; 1990 Aug; 1046(1):12-8. PubMed ID: 2397240
[TBL] [Abstract][Full Text] [Related]
20. Reduction and glucuronidation of naftazone by human and rat liver microsomes.
Herber R; Hercelin B; Van Cantfort J; De Graeve J; Fournel-Gigleux S; Taguchi T; Magdalou J
Drug Metab Dispos; 1995 Dec; 23(12):1305-14. PubMed ID: 8689937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
